receptor

  1. Study shows how to protect diabetics from heart and kidney disease

    Study shows how to protect diabetics from heart and kidney disease

    SGLT2is, also known as gliflozin, are a class of drugs that lower blood sugar by increasing its excretion in the urine, while GLP-1RAs, such as Ozempic, work by increasing insulin release and sensitivity.Impaired glucose control in diabetic patients is known to damage blood vessels in the...
  2. Study finds new therapeutic avenues in bone repair

    Study finds new therapeutic avenues in bone repair

    Birmingham [UK], Birmingham Researchers have demonstrated that a naturally occurring peptide (small protein) called PEPITEM has potential as an innovative therapy for osteoporosis and other diseases associated with bone loss, including the use of conventional drugs. (Peptide inhibitor of...
  3. Obesity, metabolic syndrome increase risk of breast cancer-related death: Study

    Obesity, metabolic syndrome increase risk of breast cancer-related death: Study

    The findings, published by Wiley Online in CANCER, the peer-reviewed journal of the American Cancer Society, indicate that MetS and obesity each have different associations with breast cancer subtype and death risk.The analysis was based on 63,330 postmenopausal women without prior breast...
  4. Acme Drugs launches DCGI-approved drugs to treat resistant
high bp

    Acme Drugs launches DCGI-approved drugs to treat resistant high bp

    Hypertension, a widespread health challenge associated with significant mortality and long-term morbidity, is a major risk factor for vascular diseases such as cerebrovascular disease, ischemic heart disease, heart failure, and renal failure. Resistant hypertension is defined as blood pressure...
  5. Scientists find potential treatment target for leading cause of blindness

    Scientists find potential treatment target for leading cause of blindness

    AMD is a condition characterized by abnormal blood vessel growth in the back of the eye.Aging, diabetes, obesity and many other chronic metabolic diseases cause excessive vascular growth and damage to the macula. ,The first line of defense is usually anti-VEGF therapy, which blocks vascular...
  6. People with rare longevity mutation may also be protected from heart disease

    People with rare longevity mutation may also be protected from heart disease

    California [US], A recent study shows that people with a rare condition called growth hormone receptor deficiency (GHRD), also known as Laron syndrome, have better heart health than people without GHRD. Which is defined by the body's inability to use its own growth hormone. It halted growth...
  7. Study sheds more light on molecular causes of different functions of opioid receptors

    Study sheds more light on molecular causes of different functions of opioid receptors

    Leipzig [Germany], Drugs targeting opioid receptors can cause serious adverse effects. Every day, thousands of people around the world die as a result of opioid overdoses, including fentanyl. A worldwide team of experts investigated the molecular mechanisms of the active compounds. The study...
Back
Top